Related Experiment Video
Updated: Jun 13, 2026
08:27
Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
Anti-adhesive membrane for pleural cavity.
Yasuharu Noishiki1, Noriyuki Shintani
1Division of Artificial Organ Science, Graduate School of Medicine, Yokohama City University, Kanazawa-ku, Yokohama, Japan. nois@yokohama-cu.ac.jp
Artificial Organs
|May 8, 2010
Summary
A novel glycerin-rich anti-adhesion membrane effectively prevented lung tissue adhesion in canine pleural surgery. This innovative membrane shows promise for reducing post-surgical complications in thoracic procedures.
Area of Science:
- Biomaterials Science
- Surgical Innovation
- Regenerative Medicine
Background:
- Post-surgical adhesions are a significant complication in thoracic surgery, particularly in the pleural cavity.
- Current anti-adhesion products are not optimized for pleural applications, leading to suboptimal outcomes.
- Preventing lung-to-chest wall adhesion is crucial for maintaining respiratory function and patient recovery.
Purpose of the Study:
- To evaluate the efficacy of a novel glycerin-based anti-adhesion membrane in preventing pleural adhesions during lung surgery.
- To compare the performance of the test membrane against a commercially available anti-adhesion product (Seprafilm).
- To elucidate the mechanism by which the glycerin membrane inhibits fibroblast migration and adhesion formation.
Main Methods:
- Development of an anti-adhesion membrane rich in glycerin for thoracic surgical applications.
- In vivo testing of the membrane in the pleural cavity of six dogs, separating the lung from the chest wall.
- Comparative analysis using Seprafilm as a control in six additional dogs.
- Histological assessment of adhesion formation and fibroblast infiltration at 3 weeks and 3 months post-implantation.
Main Results:
- The glycerin-based membrane successfully prevented adhesions between the lung and pleural cavity wall in 5 out of 6 dogs after 3 weeks.
- One dog treated with the test membrane showed no adhesions after 3 months of observation.
- Seprafilm failed to prevent pleural adhesions in all six control dogs within the 3-week observation period.
- The glycerin membrane's high water content and growth factor dispersal mechanism inhibited fibroblast migration, preventing adhesion tissue formation.
Conclusions:
- The novel glycerin-rich membrane is a highly effective anti-adhesion barrier in the pleural space during lung surgery.
- The membrane's mechanism involves creating a hydrated environment that impedes fibroblast activity, thereby preventing adhesion formation.
- This study suggests that water-based mechanisms are key to preventing post-surgical adhesions in thoracic procedures.
Related Concept Videos
01:13Pleura of the Lungs
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
01:27Tissue Membranes
A tissue membrane is a thin layer of cells that covers the outside of the body, the organs, internal passageways that lead to the exterior of the body, and the lining of the moveable joint cavities. There are two basic types of tissue membranes— connective tissue and epithelial membranes.
Connective Tissue Membranes
The connective tissue membrane is formed solely from connective tissue. These membranes encapsulate organs, such as the kidneys, and line our movable joints. A synovial membrane is...
Connective Tissue Membranes
The connective tissue membrane is formed solely from connective tissue. These membranes encapsulate organs, such as the kidneys, and line our movable joints. A synovial membrane is...
01:25Pleural Effusion I: Introduction
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
01:30Pleural Disorders: Types and Brief Description
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
01:28Pleural Effusion II: Symptoms and Management
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...